Pro-Dex Q1 sales rise 11% to $20.6 million; net income falls to $3.0 million
Pro-Dex reported fiscal first-quarter results for the period ended September 30, 2026. Net sales rose 11% to $20.6 million and operating income rose 13% to $3.5 million, but net income fell to $3.0 million, or $0.92 per diluted share, from $4.7 million, or $1.40, a year earlier. The drop in net income mainly reflects much smaller unrealized investment gains than in the prior-year quarter.
Key points
- Net sales rose $2.1 million, or 11%, to $20.6 million, led by a $3.3 million increase in medical device revenue.
- Gross margin rose to 33% from 29%, mainly due to favorable product mix.
- Net income fell to $3.0 million, or $0.92 per diluted share, from $4.7 million, or $1.40, as unrealized investment gains dropped to $73,000 from $3.3 million.
- Operating expenses rose 48% to $3.3 million, including $466,000 from the newly acquired subsidiary Advanced Precision Machining, LLC.
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.